Dr. Carl V. Crawford Jr., MD

Dr. Crawford practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Crawford's NPI, 1851566095, was assigned on April 29, 2008. Dr. Crawford graduated from Yale School of Medicine in 2001. Dr. Crawford holds New York license 231371.

Dr. Crawford's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Crawford's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Crawford is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Crawford to 1 more hospital, 2 clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crawford practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Crawford's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Crawford is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Crawford is licensed in New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis and irritable bowel syndrome (IBS) among the conditions Dr. Crawford treats.

CMS data shows 839 Medicare services from Dr. Crawford across 14 procedure codes in 2024, for 428 Medicare patients. Medicare paid $94,998 for them.

CMS counts 428 Medicare patients who saw Dr. Crawford in 2024. The largest group is 65 to 74, with 177 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crawford's median patient age at 71, with 59% women.

In 2024, Dr. Crawford wrote 420 Medicare Part D claims for 158 patients. 69% of them were for generic drugs. CMS names the drug for 193 of them, across 9 drugs with 11 or more claims each, at $36,182 in total drug cost. In 2023, CMS named 810 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Crawford for performance year 2024, reported through an alternative payment model (APM). Dr. Crawford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Crawford as offering telehealth. CMS counts 219 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Crawford, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 63 papers to Dr. Crawford, published from 2008 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Gastrointestinal Microbiome, Clostridioides difficile and Fecal Microbiota Transplantation. Dr. Crawford has published most often in Surg Endosc. Dr. Crawford's most frequent co-authors are Rasa Zarnegar, MD, Ellen J. Scherl, MD and Randy Scott Longman, MD, PhD.

Dmand AI links Dr. Crawford to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Colitis, Ulcerative and Colitis.

CMS Open Payments shows 466 general payments to Dr. Crawford from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Ferring Pharmaceuticals Inc. paid the most, $140,634.

Dr. Crawford graduated from Yale School of Medicine in 2001.

Dr. Crawford is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.